JoVE Journal
Cancer Research
Cancer Research
A subscription to JoVE is required to view this content.
Chapters
Summary
Please note that all translations are automatically generated.
Vi præsenterer her, en protokol for at producere en bispecific antistof GPC3-S-Fab i Escherichia coli. Renset GPC3-S-Fab har potent cytotoksicitet mod GPC3 positive leverkræft celler.